After determining the involvement of IL-34 in the activation of MEK/ERK and JNK/c-Jun signaling cascades in JB6 Cl41 cells, we further confirmed whether IL-34 influences the MAPK pathway in breast cancer cells. This evidence concerns the gene MAP2K7 and breast carcinoma.